Table of Contents
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outllook
2.2 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation And Scope
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Research Activities For Drug Development And Precision Medicine
3.3.1.2 Rising Adoption Of Biologics And Biosimilars
3.3.1.3 Increasing Investments In Research & Development Activities
3.3.2 Market Restraint Analysis
3.3.2.1 Regulatory And Safety Concerns With Protein Production
3.3.2.2 Dearth Of Skilled Personnel And Expertise
3.3.3 Market Opportunity Analysis
3.3.3.1 Declining Cost Of Therapeutics Recombinant Proteins And Advent Of Biosimilars
3.3.3.2 Innovative Techniques Can Decrease The Recombinant Protein Production Cost
3.4 Business Environment Analysis Tools
3.4.1 Swot Analysis, By Pest
3.4.2 Porter’s Five Forces Analysis
3.5 Penetration & Growth Prospect Mapping For Product, 2021
3.6 Recombinant Proteins Market: Covid-19 Impact Analysis
Chapter 4 Product Segment Analysis
4.1 Recombinant Proteins Market: Product Movement Analysis
4.2 Product
4.2.1 Global Recombiant Proteins Product Market, 2018 – 2030 (USD Million)
4.2.2 Cytokines &Growth Factors
4.2.2.1 Global Cytokines & Growth Factors Market, 2018 – 2030 (USD Million)
4.2.2.1.1 Interferons
4.2.2.1.1.1 Global Interferons Market, 2018 – 2030 (USD Million)
4.2.2.1.2 Interleukins
4.2.2.1.2.1 Global Interleukins Market, 2018 – 2030 (USD Million)
4.2.2.1.3 Others
4.2.2.1.3.1 Others Cytokines & Growth Factors Market, 2018 – 2030 (USD Million)
4.2.3 Antibodies
4.2.3.1 Global Antibodies Market, 2018 – 2030 (USD Million)
4.2.4 Immune Checkpoint Proteins
4.2.4.1 Global Immune Checkpoint Proteins Market, 2018 – 2030 (USD Million)
4.2.5 Virus Antigens
4.2.5.1 Global Virus Antigens Market, 2018 – 2030 (USD Million)
4.2.6 Enzymes
4.2.6.1 Global Enzymes Market, 2018 – 2030 (USD Million)
4.2.6.1.1 Kinases
4.2.6.1.1.1 Global Kinases Market, 2018 – 2030 (USD Million)
4.2.6.1.2 Metabolic Enzymes
4.2.6.1.2.1 Global Metabolic Enzymes Market, 2018 – 2030 (USD Million)
4.2.6.1.3 Others
4.2.6.1.3.1 Others Enzymes Market, 2018 – 2030 (USD Million)
4.2.7 Recombinant Regulatory Proteins
4.2.7.1 Global Recombinant Regulatory Proteins Market, 2018 – 2030 (USD Million)
4.2.8 Hormones
4.2.8.1 Global Hormones Market, 2018 – 2030 (USD Million)
4.2.9 Others
4.2.9.1 Others Product Market, 2018 – 2030 (USD Million)
4.3 Production Services
4.3.1 Global Recombiant Proteins Production Services Market, 2018 – 2030 (USD Million)
Chapter 5 Application Segment Analysis
5.1 Recombinant Proteins Market: Application Movement Analysis
5.2 Drug Discovery & Development
5.2.1 Global Drug Discovery & Development, 2018 – 2030 (USD Million)
5.3 Therapeutics
5.3.1 Global Therpeutics Market, 2018 – 2030 (USD Million)
5.3.2 Biologics
5.3.2.1 Global Biologics Market, 2018 – 2030 (USD Million)
5.3.3 Vaccines
5.3.3.1 Global Vaccines Market, 2018 – 2030 (USD Million)
5.3.4 Cell & Gene Therapies
5.3.4.1 Global Cell & Gene Therapies Market, 2018 – 2030 (USD Million)
5.3.5 Others
5.3.5.1 Others Therapeutics Market, 2018 – 2030 (USD Million)
5.4 Research
5.4.1 Global Research Market, 2018 – 2030 (USD Million)
5.5 Other
5.5.1 Other Application Market, 2018 – 2030 (USD Million)
Chapter 6 End-User Segment Analysis
6.1 Recombinant Proteins Market: End-User Movement Analysis
6.2 Pharmaceutical & Biotechnology Companies
6.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.3 Academic & Research Institutes
6.3.1 Global Academic & Research Institutes Market, 2018 – 2030 (USD Million)
6.4 Diagnostic Laboratories
6.4.1 Global Diagnostic Laboratories Market, 2018 – 2030 (USD Million)
6.5 Others
6.5.1 Other End-Users, 2018 – 2030 (USD Million)
Chapter 7 Host-Cells Segment Analysis
7.1 Recombinant Proteins Market: Host-Cells Movement Analysis
7.2 Mammalian Systems
7.2.1 Global Mammalian Systems Market, 2018 – 2030 (USD Million)
7.3 Insects Cells
7.3.1 Global Insects Cells Market, 2018 – 2030 (USD Million)
7.4 Yeast & Fungi
7.4.1 Global Yeast & Fungi Market, 2018 – 2030 (USD Million)
7.5 Bacterial Cells
7.5.1 Global Bacterial Cells Market, 2018 – 2030 (USD Million)
7.6 Others
7.6.1 Other Host-Cells, 2018 – 2030 (USD Million)
Chapter 8 Regional Outlook
8.1 Recombinant Proteins Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Europe Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 France Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Sain Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.4.2 China
8.4.2.1 China Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.4.3 India
8.4.3.1 India Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.4.4 Japan
8.4.4.1 Japan Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.6 Middle East And Africa (Mea)
8.6.1 Mea Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.6.3 Uae
8.6.3.1 Uae Recombinant Proteins Market, 2018 – 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Saudi Arabia Recombinant Proteins Market, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Thermo Fisher Scientific, Inc.
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 Abcam plc
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product/Service Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 Bio-Rad Laboratories, Inc.
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product/Service Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 Bio-Techne Corporation
9.3.4.1 Company Overview
9.3.4.1.1 R&D Systems
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Merck KGaA
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 GenScript Biotech Corporation
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 RayBiotech Life, Inc.
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Proteintech Group, Inc.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Enzo Life Sciences, Inc.
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 STEMCELL Technologies Inc
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 Sino Biological, Inc.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Abnova Corporation
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives